These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3544821)

  • 41. Cyclosporine: five years' experience in cadaveric renal transplantation.
    Merion RM; White DJ; Thiru S; Evans DB; Calne RY
    N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
    Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
    Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
    J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Oh HK; Dienst S
    Transplantation; 1988 Jan; 45(1):53-5. PubMed ID: 3276062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.
    Ettenger RB; Grimm EM
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S22-8. PubMed ID: 11583941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence and severity of acute cardiac allograft rejection with two different low-dose cyclosporine maintenance protocols.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Kober I; Wolner E
    Ann Thorac Surg; 1988 Oct; 46(4):382-8. PubMed ID: 3052335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
    J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporine-induced changes in glomerular filtration rate and urea excretion.
    Laskow DA; Curtis JJ; Luke RG; Julian BA; Jones P; Deierhoi MH; Barber WH; Diethelm AG
    Am J Med; 1990 May; 88(5):497-502. PubMed ID: 2337107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT; Antolick A; Ring WS
    J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperuricemia after renal transplantation.
    Gores PF; Fryd DS; Sutherland DE; Najarian JS; Simmons RL
    Am J Surg; 1988 Nov; 156(5):397-400. PubMed ID: 3056057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients.
    Solez K; Racusen LC; Marcussen N; Slatnik I; Keown P; Burdick JF; Olsen S
    Kidney Int; 1993 May; 43(5):1058-67. PubMed ID: 8510383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A controlled trial of steroids in cyclosporine-treated renal transplant recipients.
    Griffin PJ; Da Costa CA; Salaman JR
    Transplantation; 1987 Apr; 43(4):505-8. PubMed ID: 3554643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporine immunosuppression.
    Canafax DM; Ascher NL
    Clin Pharm; 1983; 2(6):515-24. PubMed ID: 6360494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients.
    Dieterle A; Gratwohl A; Nizze H; Huser B; Mihatsch MJ; Thiel G; Tichelli A; Signer E; Nissen C; Speck B
    Transplantation; 1990 Jun; 49(6):1093-100. PubMed ID: 2193442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine.
    Barton CH; Vaziri ND; Martin DC; Choi S; Alikhani S
    Am J Med; 1987 Oct; 83(4):693-9. PubMed ID: 3314493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclosporine: a new immunosuppressive agent for organ transplantation.
    Cohen DJ; Loertscher R; Rubin MF; Tilney NL; Carpenter CB; Strom TB
    Ann Intern Med; 1984 Nov; 101(5):667-82. PubMed ID: 6385799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months.
    Morris PJ; French ME; Dunnill MS; Hunnisett AG; Ting A; Thompson JF; Wood RF
    Transplantation; 1983 Sep; 36(3):273-7. PubMed ID: 6310833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.